Indeed, P2X7 receptor ligands have been tested, with encouraging results, in preclinical models of inflammation (chronic pulmonary diseases, glomerulonephritis, rheumatoid arthritis, multiple sclerosis) [22]. The gene discussed is P2RX7; the disease is multiple sclerosis.